undamentalytics Newsletter
Sign in

Sera Prognostics, Inc. revenue

Sera Prognostics, Inc.'s revenue was $81,000 in fiscal 2025, up 5.2% on the year before. Since fiscal 2020 ($25,000) it has grown at a compound 26.5% a year. Over the last twelve months it was $70,000.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue2582268306778170
Growth on the year before—+228.0%+226.8%+14.2%−74.8%+5.2%—
Gross profit———96−5−83−105
Gross margin———31.4%−6.5%——

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Life Sciences Tools & Services: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Sera Prognostics, Inc. $70,000 -35.2% -42.8%
Aclarion, Inc. $83,769 33.1% 0.2%
Ispecimen Inc. $466,302 -92.1% -64.1%
YD Bio Ltd $596,817 16.9% —
Quantum-si Inc $1.6m -53.0% 51.8%
Bionexus Gene Lab Corp $3.1m -67.3% -32.9%

Compare with peers

Head to head: ACON vs SERAISPC vs SERASERA vs YDES

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Sera Prognostics, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Sera Prognostics, Inc.